Professor Gerald Watts
University of Western Australia, Perth (Australia)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
RNA interference targeting hepatic angiopoietin-like protein 3 results in prolonged reductions in serum triglyceride and non-HDL cholesterol concentrations: first human results with ARO-ANG3
Event: ESC Congress 2023
Topic: Chronic Heart Failure
Session: Nature Medicine: highlights in cardiovascular research
RNAi inhibition of angiopoietin-like protein 3 (ANGPTL3) with ARO-ANG3 mimics the lipid and lipoprotein profile of familial combined hypolipidemia
Event: ESC Congress 2020
Topic: Lipid-Lowering Agents
Session: Novel Approaches to Lipid Lowering Therapy
Factorial effects of evolocumab and atorvastatin on lipoprotein metabolism: the FLOREY stable isotope study
Event: ESC Congress 2016
Topic: CAD and comorbidities
Session: Comorbidities and risk for CAD
RNAi inhibition of angiopoietin-like protein 3 (ANGPTL3) with ARO-ANG3 mimics the lipid and lipoprotein profile of familial combined hypolipidemia
Event: ESC Asia with APSC & AFC 2020
Topic: Lipid-Lowering Agents
Session: Abstract Programme
ESC 365 is supported by
